Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.

@article{Andersen2003PrimaryTW,
  title={Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.},
  author={Niels Smedegaard Andersen and Lone Bredo Pedersen and Erkki Elonen and Anna Johnson and Arne Kolstad and Kaarle Franssila and Ruth Langholm and Elisabeth Methner Ralfkiaer and M. A. Akerman and Mikael Eriksson and Outi Kuittinen and Christian Hartmann Geisler},
  journal={European journal of haematology},
  year={2003},
  volume={71 2},
  pages={73-80}
}
OBJECTIVES The aim of the first Nordic mantle cell lymphoma (MCL) protocol was to study the clinical significance of an augmented CHOP induction chemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) and to examine the prognostic significance of stem cell contamination rates in newly diagnosed patients with MCL. PATIENTS AND METHODS Forty-one newly diagnosed patients below 66 yr were enrolled and given three series of an augmented CHOP regimen… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

Therapeutic options in mantle cell lymphoma.

Leukemia & lymphoma • 2008
View 19 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…